BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 7074640)

  • 1. Immune status of untreated patients with Hodgkin's disease and prognosis.
    Björkholm M; Wedelin C; Holm G; Ogenstad S; Johansson B; Mellstedt H
    Cancer Treat Rep; 1982 Apr; 66(4):701-9. PubMed ID: 7074640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors in Hodgkin's disease. II. Role of the lymphocyte defect.
    Björkholm M; Holm G; Mellstedt H; Johansson B; Killander D; Sunblad R; Söderberg G
    Scand J Haematol; 1978 Apr; 20(4):306-18. PubMed ID: 653310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired lymphocyte transformation in Hodgkin's disease. Evidence for depletion of circulating t-lymphocytes.
    Matchett KM; Huang AT; Kremer WB
    J Clin Invest; 1973 Aug; 52(8):1908-17. PubMed ID: 4541673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Persisting deficiency of cell mediated immunity in Hodgkin's disease in complete remission (author's transl)].
    Lang JM; Bigel P; Giron C; Faradji A; Oberling F; Mayer S
    Nouv Presse Med; 1979 Nov; 8(44):3629-32. PubMed ID: 316521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocyte counts and functions in arterial and venous splenic blood of patients with Hodgkin's disease. Evidence for elimination of spontaneously DNA synthesizing cells in the spleen.
    Björkholm M; Holm G; Askergren J; Mellstedt H
    Clin Exp Immunol; 1983 Jun; 52(3):485-92. PubMed ID: 6872314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune function of successfully treated lymphoma patients.
    King GW; Yanes B; Hurtubise PE; Balcerzak SP; LoBuglio AF
    J Clin Invest; 1976 Jun; 57(6):1451-60. PubMed ID: 932190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persisting lymphocyte deficiences during remission in Hodgkin's disease.
    Björkholm M; Holm G; Mellstedt H
    Clin Exp Immunol; 1977 Jun; 28(3):389-93. PubMed ID: 302164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunodeficiency in Hodgkin's disease and its relation to prognosis.
    Björkholm M
    Scand J Haematol Suppl; 1978; 33():1-74. PubMed ID: 305101
    [No Abstract]   [Full Text] [Related]  

  • 9. Restoration of cellular immune response by levamisole in patients with Hodgkin's disease.
    Levo Y; Rotter V; Ramot B
    Biomedicine; 1975 Jun; 23(6):198-200. PubMed ID: 1082352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous lymphocyte proliferation and depressed cellular immunity in Hodgkin's disease.
    Shiftan TA; Caviles AP; Mendelsohn J
    Clin Exp Immunol; 1978 Apr; 32(1):144-52. PubMed ID: 668190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro evidence of normal lymphocyte function in some patients with Hodgkin's disease and negative delayed cutaneous hypersensitivity.
    Churchill WH; Rocklin RR; Moloney WC; David JR
    Natl Cancer Inst Monogr; 1973 May; 36():99-106. PubMed ID: 4583000
    [No Abstract]   [Full Text] [Related]  

  • 12. Quantitation of immunocompetence in Hodgkin's disease.
    Faguet GB
    J Clin Invest; 1975 Oct; 56(4):951-7. PubMed ID: 1159096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SPLEEN/PATHOL.
    Bukowski RM; Noguchi S; Hewlett JS; Deodhar S
    Am J Clin Pathol; 1976 Jan; 65(1):30-9. PubMed ID: 1082240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous rosette-forming capacity of T-lymphocytes in Hodgkin's disease.
    Bodolay E; Berényi E; Sonkoly I; Szegedi G
    Acta Med Hung; 1984; 41(2-3):113-9. PubMed ID: 6611543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implications of persistent T cell abnormalities for the etiology of Hodgkin's disease.
    Fisher RI
    Cancer Treat Rep; 1982 Apr; 66(4):681-7. PubMed ID: 6210434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hodgkin's disease: study of delayed hypersensitivity of 64 non treated patients. Value of epicutaneous test using croton oil].
    Goasguen J; Leblay R; Guerin D; Le Prise PY; Richier JL
    Sem Hop; 1977 Jan; 53(4):219-25. PubMed ID: 189435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Assays in delayed hypersensitivity in the course of Hodgkin's disease].
    Bernadou A; Zittoun R; Blanc CM; Smadja R; Bousser J
    Ann Med Interne (Paris); 1970 Mar; 121(3):301-11. PubMed ID: 5507504
    [No Abstract]   [Full Text] [Related]  

  • 18. Distinguishing features of the immunology of Hodgkin's disease in children.
    Tan CT; De Sousa M; Good RA
    Cancer Treat Rep; 1982 Apr; 66(4):969-75. PubMed ID: 7074657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blastogenic transformation of lymphocytes following phytohaemagglutinin treatment in vitro in malignant lymphomas. I. Hodgkin's disease. (Correlation with immunity response of the cellular type and with the clinical status).
    Libánský J; Lukásová M; Pinosová I
    Neoplasma; 1973; 20(1):51-60. PubMed ID: 4702205
    [No Abstract]   [Full Text] [Related]  

  • 20. Lymphopenia: a bad prognostic factor in Hodgkin's disease.
    Hancock BW; Dunsmore IR; Swan HT
    Scand J Haematol; 1982 Sep; 29(3):193-9. PubMed ID: 7146822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.